The former head of Swisse Wellness Oliver Horn (pictured) has been appointed as the CEO of Australia’s leading cannabis company Elixinol (ASX: EXL).
Horn’s experience with the vitamin giant will serve him well at Elixinol, a cannabis stock specialising in cannabidiol dietary supplements and topical products.
The appointment is effective immediately and will see Horn step up from the position of non-executive director after just two weeks in the role. Horn will replace Startos Karousos as CEO.
Elixinol chairman and founder Paul Benhaim says the appointment of Horn will position the company to lead within the global cannabis and hemp industry.
“Since Oliver joined the board earlier this month, it became apparent that he could create immense value in a leadership position,” Benhaim said.
“He is a natural people leader, has great commercial acumen, and brings well needed global experience to the role.”
In addition to Horne’s time at Swisse, he has held leadership positions at Treasury Wine Estates and has a background in corporate finance having started his career at Deutsche Bank in Germany.
“I chose to join Elixinol Global because it has an outstanding reputation for quality, transparency and efficacy,” says Horne.
“We are in the enviable of being a long-term global growth category, with a good brand, and strong market research.”
“My vision is to build a branded global consumer products business, built on a very positive culture which does good for people and the planet. I will be driving an agile and transparent business, that is at the forefront of innovation.”
Shares in Elixinol are up 1.28 per cent to $0.40 per share at 3:07pm AEST.
Business News Australia